eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Allen & Hanburys Ltd
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 13/09/2011
SPC Flixonase Aqueous Nasal Spray

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 10 date of revision of the text
Updated on 26/02/2010 and displayed until 13/09/2011
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Updated on 24/04/2007 and displayed until 26/02/2010
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 10 date of revision of the text
Updated on 26/09/2005 and displayed until 24/04/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 08/04/2005 and displayed until 26/09/2005
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.8 - Undesirable Effects
Updated on 17/01/2005 and displayed until 08/04/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 11/01/2005 and displayed until 17/01/2005
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 29/06/2004 and displayed until 11/01/2005
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 10/08/2001 and displayed until 29/06/2004
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 28/06/2001 and displayed until 10/08/2001
Reasons for adding or updating:
  • Change to section 5 - Pharmacological Properties
Updated on 18/08/2000 and displayed until 28/06/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 12/04/2000 and displayed until 18/08/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 01/12/1999 and displayed until 12/04/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 01/12/1999
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  fluticasone propionate